Cargando…

Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography

BACKGROUND: Dual antiplatelet therapy with clopidogrel and aspirin is the standard of care for patients undergoing percutaneous coronary intervention (PCI). OBJECTIVE: To determine the clinical characteristics associated with high on-treatment platelet reactivity (HPR) of patients undergoing PCI aft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xu-Min, Han, Wen-Zheng, Qiu, Xing-Biao, Fang, Wei-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832659/ https://www.ncbi.nlm.nih.gov/pubmed/27326080 http://dx.doi.org/10.1136/heartasia-2013-010296

Ejemplares similares

Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

The Potential Value of Near Patient Platelet Function Testing in PCI: Randomised Comparison of 600 mg versus 900 mg Clopidogrel Loading Doses
por: Hobson, Alex R., et al.
Publicado: (2010)

Is it possible? Predicting complications and morbidity in surgical patients on clopidogrel therapy with Thrombelastography Platelet Mapping
por: Callender, Rashida, et al.
Publicado: (2013)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Gjermeni, Diona, et al.
Publicado: (2022)

Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
por: Cakal, Sinem, et al.
Publicado: (2021)

Clopidogrel Loading Dose 300 vs. 600 mg in Patients Undergoing One-Stop Hybrid Coronary Revascularization: A Prospective Single-Center Randomized Pilot Study
por: Guo, Yulin, et al.
Publicado: (2021)

Residual platelet reactivity is preferred over platelet inhibition rate in monitoring antiplatelet efficacy: insights using thrombelastography
por: Wu, Hong-yi, et al.
Publicado: (2019)

Platelet reactivity after clopidogrel loading in patients with acute ischemic stroke
por: Enomoto, Yukiko, et al.
Publicado: (2022)

Effects of 600 mg versus 300 mg Loading Dose of Clopidogrel in Asian Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Long-Term Follow-Up Study
por: Song, Pil Sang, et al.
Publicado: (2012)

CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome
por: Liu, Jian, et al.
Publicado: (2015)

Thrombelastography and sepsis
por: Puana, Rudolph, et al.
Publicado: (2007)

Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography
por: Solomon, Cristina, et al.
Publicado: (2015)

Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome
por: Peng, Wenxing, et al.
Publicado: (2019)

Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome
por: Chen, Yunxian, et al.
Publicado: (2022)

Platelet reactivity unit (PRU) in patients undergoing elective PCI: Rethinking the optimal cut point
por: Sharifi, Hassan, et al.
Publicado: (2017)

The Role of Thrombelastography in Multiple Trauma
por: Jeger, Victor, et al.
Publicado: (2011)

Thrombelastography Guides Transfusion Strategy
por: Bay Nielsen, Henning
Publicado: (2009)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
por: Kille, Alexander, et al.
Publicado: (2021)

Admission thrombelastography does not guide dose adjustment of enoxaparin in trauma patients
por: Hayes, Hannah V., et al.
Publicado: (2020)

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial
por: Lee, Dong-Hyun, et al.
Publicado: (2013)

Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database
por: Wang, Weihao, et al.
Publicado: (2021)

Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)

Thrombelastography and tromboelastometry in assessing coagulopathy in trauma
por: Johansson, Pär I, et al.
Publicado: (2009)

Impact of On-Clopidogrel Platelet Reactivity on Incidence of Peri-Interventional Bleeding in Patients Undergoing Transcatheter Aortic Valve Implantation
por: Kille, Alexander, et al.
Publicado: (2022)

Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel
por: Bouida, W., et al.
Publicado: (2017)

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007)

Procoagulant activity and thrombelastography in Korean hemorrhagic fever.
por: Lee, M., et al.
Publicado: (1986)

The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction
por: Cho, Jung-Hyun, et al.
Publicado: (2010)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
por: Kim, Sehun, et al.
Publicado: (2021)

Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium
por: Verma, Shefali Setia, et al.
Publicado: (2020)

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry
por: Völz, Sebastian, et al.
Publicado: (2020)

Effect of thrombelastography on timing of coronary artery bypass grafting
por: Yang, Zhiyuan, et al.
Publicado: (2018)

Revisiting Hartert’s 1962 Calculation of the Physical Constants of Thrombelastography
por: Hochleitner, Gerald, et al.
Publicado: (2015)

Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
por: Bai, Long, et al.
Publicado: (2022)

Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients
por: Cheng, Daye, et al.
Publicado: (2020)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel
por: Geisler, Tobias, et al.
Publicado: (2015)

The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions
por: Tekkeşin, Ahmet İlker, et al.
Publicado: (2016)

Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment
por: Yu, Shushu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v44fs9nkthkssdid35hklf2pep